Short answer
Insulet Corporation (PODD) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 fiscal 2026 results for quarter ended June 30, 2026.
Insulet Corporation 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 fiscal 2026 results for quarter ended June 30, 2026
- Press release furnished as Exhibit 99.1 contains financial results and management commentary
- August 5, 2026 announcement provides the market’s primary earnings update
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $801.7M, up 23.5%; growth exceeded constant-currency guidance high end of 22%
- Omnipod revenue $795.9M, up 24.6%; international growth 35.5% outpaced U.S. growth of 20.1%
- Adjusted operating margin 19.3%, up over 140 basis points; GAAP margin fell to 16.2% after $21.9M medical-device correction costs
- Adjusted EPS $1.66, up 41.5%; GAAP net income $95.0M versus $22.5M, aided by absence of prior-year debt-extinguishment losses
- FY 2026 total revenue growth guidance reduced to 20%-22% from 21%-23%, while adjusted EPS growth guidance exceeds 30%
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Insulet Corporation 8-K filings
Get the next PODD 8-K as it lands
Follow PODD for push alerts, or ask the research agent what this filing means.